Medico Remedies experienced a significant profit increase of 35% YoY in Q4 FY26, reaching a record high of ₹5.86 Cr. However, a 3.2% decrease in quarterly revenue might indicate potential concerns about profit margin stability and long-term growth.

Medico Remedies will disclose their Q2 financial results on May 21, 2026, following a board meeting for this purpose. Investors and stakeholders should keep an eye out for the upcoming financial update from the company.

Medico Remedies faced fines totaling ₹63,720 from NSE and BSE for violating SEBI Regulation 6(1). The company resolved the issue by complying with the regulations before February 18, 2026, with no significant financial consequences reported.